The United States Food and Drug Administration (FDA) has granted De Novo authorisation for Lumenis’ newest intense pulsed light (IPL) device for improving signs
Optometry NSW/ACT will host a one day CPD program for optometrists on Sunday 27 February, 2022 at National Gallery Australia in Canberra, from 9am
Government investment in public cataract services should be a health policy priority, according to a report commissioned by Vision 2020.
A new rapid screening test, developed by a research team of engineers and ophthalmologists led by RMIT University, could help advance early detection of
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
